# GELATIN

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid5050501
Categories: beauty, cleaning, food, industrial, pharma
Functions: Adhesion/cohesion promoter, Binder, Chemical reaction regulator, Film former, Fragrance, Mucoadhesive, Pharmaceutical, Processing aids not otherwise specified, Softener and conditioner, Surface modifier, Thickening agent, Viscosity modifier
Identifier: DTXSID5050501

> GELATIN is used as adhesion/cohesion promoter / binder. EPA CPDat observed this chemical in 501 composition records across product categories including Personal care, Specialty occupational products, Batteries. Assessed from 48 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 501 composition records across product categories including Personal care, Specialty occupational products, Batteries.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 501 composition records across product categories including Personal care, Specialty occupational products, Batteries. EPA CPDat classifies this chemical for functional uses including Mucoadhesive, Film former, Viscosity modifier.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 102 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE; Maximum daily exposure: 252 mg
- US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.05 ml
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 16 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 14 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: 1.3 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 20 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 14 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 34.8 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: DROPS; Potency: 50 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 6436 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 288 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 65 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 1791 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1229 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 1042 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: PASTILLE; Potency: 143 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Potency: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Potency: 34.8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 46 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 42.12 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 19 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 239 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 57 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: NA
- US: inactive ingredient database — Route: PERIODONTAL; Dosage form: TABLET; Potency: 3.44 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: CAPSULE; Potency: NA
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: 100 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 16 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 14 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 13 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 1050 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: NA
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._